Role of MRI for staging of rectal cancer

Expert Review of Anticancer Therapy

Volumn 9, Issue 4, 2009, Pages 469-481

  Jhaveri, Kartik S ^a   Sadaf, Arifa ^b  

^a 610 University Avenue ^*  (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

MRI; Neoadjuvant therapy; Neoplasm; Preoperative staging; Prognostic factor; Rectum; Surgery

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; HUMAN; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS CANCER; PREOPERATIVE EVALUATION; RECTOSCOPY; RECTUM CANCER; RECTUM RESECTION; REVIEW; RISK FACTOR; TUMOR DIFFERENTIATION; ADJUVANT THERAPY; CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MANAGEMENT; METASTASIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PELVIS TUMOR; PREOPERATIVE CARE; RADIOGRAPHY; RECTUM TUMOR; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

CARCINOMA; COMBINED MODALITY THERAPY; DISEASE MANAGEMENT; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIC NEOPLASMS; PREOPERATIVE CARE; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67650293481     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/ERA.09.13     Document Type: Review

References (101)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics 2006. CA Cancer J. Clin. 56(2), 106-130 (2006).
2. Iafrate F, Laghi A, Paolantonio P et al. Preoperative staging of rectal cancer with MR imaging: correlation with surgical and histopathologic findings. Radiographics 26(3), 701-714 (2006).
3. Heald RJ, Moran BJ. Embryology and anatomy of rectum. Semin. Surg. Oncol. 15(2), 66-71 (1998).
4. Herbst F. Pelvic radiological imaging: a surgeon's perspective. Eur. J. Radiol. 47(2), 135-141 (2003).
5. Holm T, Cedermark B, Rutqvist LE. Local recurrence of rectal adenocarcinoma after 'curative' surgery with and without preoperative radiotherapy. Br. J. Surg. 81(3), 452-455 (1994).
6. Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeon related factors and outcome in rectal cancer. Ann. Surg. 227(2), 157-167 (1998).
7. Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum carcinoma - experience of the German multicentre study SGCRC. German Study Group Colorectal Carcinoma. Tumori 81(3 Suppl.), 60-64 (1995).
8. Heald RJ. Total mesorectal excision is optimal surgery for rectal cancer: a Scandinavian consensus. Br. J. Surg. 82(10), 1297-1299 (1995).
9. Quirke P, Durdy P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2(8514), 996-999 (1986).
10. Adam IJ, Mohamdee MO, Martin IG et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344(8924), 707-711 (1994).
11. Abulafi AM, Williams NS. Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br. J. Surg. 81(1), 7-19 (1994).
12. Sagar PM, Pemberton JH. Surgical management of locally recurrent rectal cancer. Br. J. Surg. 83(3), 293-304 (1996).
13. Wibe A, Rendedall PR, Svensson E et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for cancer. Br. J. Surg. 89, 327-334 (2002).
14. Den Dulk M, Van De Velde CJH. Quality assurance in surgical oncology: the tale of the Dutch Rectal Cancer TME Trial. J. Surg. Oncol. 97 (1), 5-7 (2008).
15. Marijnen CA, Nagtegaal ID, Kapiteijn E et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 55(5), 1311-1320 (2003).
16. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1(8496), 1479-1482 (1986).
17. Grabbe E, Lierse W, Winkler R. The perirectal fascia: morphology and use in staging of rectal carcinoma. Radiology 149(1), 241-246 (1983).
18. Goh V, Halligan S. Bartram CI. Local radiological staging of rectal cancer. Clin. Radiol. 59(3), 215-226 (2004).
19. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery - the clue to pelvic recurrence. Br. J. Surg. 69(10), 613-616 (1982).
20. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. 345(9), 638-646 (2001).
21. MacFarlane JK, Ryall RDH, Heald RJ. Mesorectal excision for rectal cancer. Lancet 341(8843), 457-460 (1993).
22. Compton CG, Greene FL. The staging of colorectal cancer: 2004 and beyond. CA Cancer J. Clin. 54, 295-308 (2004).
23. Bertangoli MM. Doing our best: surgery for rectal cancer. Gut 57(12), 1643-1645 (2008).
24. Reerink O, Verschueren R, Szabo B et al. A favourable pathological stage after neo-adjuvant radiochemotherapy in patients with initially irresectable rental cancer correlates with a favourable prognosis. Eur. J. Cancer 39(2), 192-195 (2003).
25. Thoeni RF, Moss AA, Schnyder P, Margulis AR. Detection and staging of primary rectal and rectosigmoid cancer by computed tomography. Radiology 141(1), 135-138 (1981).
26. Grabbe E, Lierse W, Winkler R. The perirectal fascia: morphology and use in staging of rectal carcinoma. Radiology 149(1), 241-246 (1983).
27. Shank B, Dershaw DD, Caravelli J, Barth J, Enker W. A prospective study of the accuracy of preoperative computed tomographic staging of patients with biopsy-proven rectal carcinoma. Dis. Colon Rectum 33(4), 285-290 (1990).
28. Butch RJ, Stark DD, Wittenberg J et al. Staging rectal cancer by MR and CT. AJR Am. J. Roentgenol. 146(6), 1155-1160 (1986).
29. Regina GH, Geerard LB. Rectal cancer: review with emphasis on MR imaging. Radiology 232(2), 335-346 (2004).
30. Hadfield MB, Nicholson AA, MacDonald AW. Preoperative staging of rectal carcinoma by magnetic resonance imaging with a pelvic phased-array coil. Br. J. Surg. 84(4), 529-531 (1997).
31. Beets-Tan RG, Beets GL, Van der Hoop AG et al. High-resolution magnetic resonance imaging of the anorectal region without an endocoil. Abdom. Imaging 24(6), 576-584 (1999).
32. Blomqvist L, Machado M, Rubio C et al. Rectal tumor staging: MR imaging using pelvic phased-array and endorectal coils vs endoscopic ultrasonography. Eur. Radiol. 10(4), 653-660 (2000).
33. Beets-Tan RG, Beets GL, Vliegen RF et al. Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgery. Lancet 357 (9255), 497-504 (2001).
34. Blomqvist L, Holm T, Rubio C, Hindmarsh T. Rectal tumors: MR imaging with endorectal and/or phased-array coils, and histopathological staging on giant sections - a comparative study. Acta Radiol. 38(3), 437-444 (1997).
35. Brown G, Richards CJ, Newcombe RG et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 211(1), 215-222 (1999).
36. Brown G, Daniels IR, Richardson C, Revell P, Peppercorn D, Bourne M. Techniques and trouble-shooting in high spatial resolution thin slice MRI for rectal cancer. Br. J. Radiol. 78 (927), 245-251 (2005).
37. Mercury study group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer; results of the MERCURY study group. Radiology 243(1), 132-139 (2007).
38. Vliegen RF, Beets GL, von Meyenfeldt MF et al. Rectal cancer: MR imaging in local staging - is gadolinium-based contrast material helpful? Radiology 234(1), 179-188 (2005).
39. Taylor FGM, Swift RI, Blomqvist L, Brown G. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR Am. J. Roentgenol. 191(6), 1827-1835 (2008).
40. Goh JS, Goh JP, Wansaicheong GK. Methylcellulose as a rectal contrast agent for MR imaging of rectal carcinoma. AJR Am. J. Roentgenol. 178(5),1145-1146 (2002).
41. Urban M, Rosen HR, Holbling N et al. MR imaging for the preoperative planning of sphincter-saving surgery for tumors of the lower third of the rectum: use of intravenous and endorectal contrast materials. Radiology 214(2), 503-508 (2000).
42. Kim Sh, Lee JM, Lee MN, Kim GH, Han JK, Choi BI. Sonography transmission gel as endorectal contrast agent for tumor visualization in rectal cancer. AJR Am. J. Roentgenol. 191(1), 186-189 (2008).
43. Slatera A, Halligana S, Taylora SA, Marshall M. Distance between the rectal wall and mesorectal fascia measured by MRI: effect of rectal distension and implications for preoperative prediction of a tumour-free circumferential resection margin. Clin. Radiol. 61(1), 65-70 (2006).
44. Kim MJ, Lim JS, Oh YT et al. Preoperative MRI of rectal cancer with and without rectal water filling: an intraindividual comparison. AJR Am. J. Roentgenol. 182(6), 1469-1476 (2004).
45. Gualdi GF, Casciani E, Guadalaxara A, d'Orta C, Polettini E, Pappalardo G. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: comparison with histologic findings. Dis. Colon Rectum 43(3), 338-345 (2000).
46. Maldjian C, Smith R, Kilger A, Schnall M, Ginsberg G, Kochman M. Endorectal surface coil MR imaging as a staging technique for rectal carcinoma: a comparison study to rectal endosonography. Abdom. Imaging 25(1), 75-80 (2000).
47. Hunerbein M, Pegios W, Rau B, Vogl TJ, Felix R, Schlag PM. Prospective comparison of endorectal ultrasound, three-dimensional endorectal ultrasound, and endorectal MRI in the preoperative evaluation of rectal tumors: preliminary results. Surg. Endosc. 14(11),1005-1009 (2000).
48. Zhang XM, Zhang HL, Yu D et al. 3-T MRI of rectal carcinoma: preoperative diagnosis, staging, and planning of sphincter-sparing surgery. AJR Am. J. Roentgenol. 190(5), 1271-1278 (2008).
49. Nelson H, Pertelli N, Carlin A et al. Guidelines 2000 for colon and rectal cancer surgery. J. Natl Cancer Inst. 93(8), 583-596 (2001).
50. Brown G, Kirkham A, Williams GT et al. High-resolution MRI of the anatomy important in total mesorectal excision of the rectum. AJR Am. J. Roentgenol. 182(2), 431-439 (2004).
51. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br. J. Surg. 90(3), 355-364 (2003).
52. Schnall MD, Furth EE, Rosato EF, Kressel HY. Rectal tumor stage: correlation of endorectal MR imaging and pathologic findings. Radiology 190(3), 709-714 (1994).
53. Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, Hermanek P. The prognostic inhomogeneity in pT3 rectal carcinomas. Int. J. Colorectal Dis. 16(5), 298-304 (2001).
54. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH; Pathology Review Committee. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am. J. Surg. Pathol. 26(3), 350-357 (2002).
55. Gagliardi G, Bayar S, Smith R, Salem RR. Preoperative staging of rectal cancer using magnetic resonance imaging with external phase-arrayed coils. Arch. Surg. 137(4), 447-451(2002).
56. Beets-Tan RG, Beets GL, Borstlap AC et al. Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI? Abdom. Imaging 25(5), 533-541 (2000).
57. Blomqvist L, Holm T, Nyren S, Svanstrom R, Ulvskog Y, Iselius L. MR imaging and computed tomography in patients with rectal tumors clinically judged as locally advanced. Clin. Radiol. 57(3), 211-218 (2002).
58. Reerink O, Verschueren R, Szabo B, Hospers GA, Mulder NH. A favourable pathological stage after neo-adjuvant radiochemotherapy in patients with initially irresectable rectal cancer correlates with a favourable prognosis. Eur. J. Cancer 39(2), 192-195 (2003).
59. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int. J. Colorectal Dis. 12(1),19-23 (1997).
60. Kuo LJ, Chern MC, Tsou MH et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis. Colon Rectum 48(1), 23-28 (2005).
61. Chen CC, Lee RC, Lin JK, Wang LW, Yang SH. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis. Colon Rectum 48(4), 722-728 (2005).
62. Jonas J, Baahr R. Neoadjuvant chemoradiation treatment impairs accuracy of MRI staging in rectal carcinoma. Gut 55, 1214-1215 (2006).
63. Vliegen RFA, Beets GL, Lammering G et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of mr imaging for prediction. Radiology 246(2), 454-462 (2008).
64. Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 94(4), 1121-1130 (2002).
65. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int. J. Colorectal Dis. 12(1), 19-23 (1997).
66. Salerno G, Chau I, Tait D, Cunningham D, Brown G. Interpretation of postchemo-radiation MRI compared with histopathology in low rectal cancer. Colorectal Dis. 9(1 Suppl.), 92-93 (2007).
67. Kremser C, Judmaier W, Hein P, Griebel J, Lukas P, de Vries A. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlentherapie und Onkologie 179(9), 641-649 (2003).
68. Nagtegaal ID, Velde CJHV, Marijnen CAM et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J. Clin. Oncol. 23(36), 9257-9264 (2005).
69. Marr R, Birbeck KF, Garvican J et al. The modern abdominoperineal excision - the next challenge after total mesorectal excision: a clinical and morphometric study. Ann. Surg. 242(1), 74-82 (2005).
70. Shihab OC, Moran BJ, Heald RJ, Quirke P, Brown G. MRI staging of low rectal cancer. Eur. Radiol. 19(3), 643-650 (2008).
71. Holzer B, Urban M, Hölbling N et al. Magnetic resonance imaging predicts sphincter invasion of low rectal cancer and influences selection of operation. Surgery 133(6), 656-661 (2003).
72. Bokey EL, Chapuis PH, Dent OF et al. Factors affecting survival after excision of the rectum for cancer: a multivariate analysis. Dis. Colon Rectum 40(1), 3-10 (1997).
73. Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis. Colon Rectum 34(9), 798-804 (1991).
74. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC. The clinical significance of invasion of veins in cancer of the rectum. Br. J. Surg. 67(6), 439-442 (1998).
75. Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br. J. Surg. 95(2), 229-236 (2008).
76. Sugihara K, Kobayashi H, Kato T et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis. Colon Rectum 49(11), 1663-1672 (2006).
77. Moriya Y, Sugihara K, Akasu T, Fujita S. Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J. Surg. 21(7), 728-732 (1997).
78. Billingham RP. Extended lymphadenectomy for rectal cancer: cure vs quality of life. Int. Surg. 79(1), 11-22 (1994).
79. Lahaye MJ, Engelen SM, Nelemans PJ et al. Imaging for predicting the risk factors - the circumferential resection margin and nodal disease - of local recurrence in rectal cancer: a meta-analysis. Semin. Ultrasound CT MR 26(4), 259-268 (2005).
80. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stiker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - a metaanalysis. Radiology 232(3), 773-783 (2004).
81. Brown G, Richards CJ, Bourne MW et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 227(2), 371-377 (2003).
82. Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur. J. Radiol. 52(1), 78-83 (2004).
83. Will O, Purkayastha S, Chan C et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol. 7(1), 52-60 (2006).
84. Koh D, Brown G, Temple L et al. Rectal cancer: mesorectal lymph nodes at MR imaging with UPSO versus histopathologic findings - initial observations. Radiology 231(1), 91-99 (2004).
85. Tsunoda Y, Ito M, Fujii H, Kuwano H, Saito N. Preoperative diagnosis of lymph node metastases of colorectal cancer by FDGPET/CT. Jpn J. Clin. Oncol. 38(5), 347-353 (2008).
86. Kim MY, Kim AY, Ha HK, Kim N, Park B-W, Kim JK. MRI in rectal cancer: added value of diffusion-weighted imaging (DWI) for discrimination of metastatic lymph nodes. Presented at: 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, USA, 25-30 November 2007.
87. Blomqvist L, Ohlsen H, Hindmarsh T, Jonsson E, Holm T. Local recurrence of rectal cancer: MR imaging before and after oral superparamagnetic particles vs contrast-enhanced computed tomography. Eur. Radiol. 10(9), 1383-1389 (2000).
88. Pema PJ, Bennett WF, Bova JG, Warman P. CT vs MRI in diagnosis of recurrent rectosigmoid carcinoma. J. Comput. Assist. Tomogr. 18, 256-261 (1994).
89. Hallbook O, Pahlman L, Krog M, Wexner SD, Sjodahl R. Randomized comparison of straight and colonic J pouch anastomosis after low anterior resection. Ann. Surg. 224(1), 58-65 (1996).
90. Mantyh CR, Hull TL, Fazio W. Coloplasty in low colorectal anastomosis: manometric radiological appearances in pelvis after rectal cancer surgery. manometric and functional comparison with straight and colonic J-pouch anastomosis. Dis. Colon Rectum 44(1), 37-42 (2001).
91. Z'graggen K, Maurer CA, Buchler MW. Transverse coloplasty pouch. A novel neorectal reservoir. Dig. Surg. 16, 363-366 (1999).
92. Tan PL, Chan CHL, Moore NR. Radiological appearances in pelvis after rectal cancer surgery. Clin. Radiol. 60(8), 846-855 (2005).
93. Dicle O, Obuz F, Cakmakci H. Differentiation of recurrent rectal cancer and scarring with dynamic MR imaging. Br. J. Radiol. 72(864), 1155-1159 (1999).
94. Muller-Schimpfle M, Brix G, Layer G et al. Recurrent rectal cancer: diagnosis with dynamic MR imaging. Radiology 189(3), 881-889 (1993).
95. Kinkel K, Tardivon AA, Soyer P et al. Dynamic contrastenhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients. Radiology 200(2), 453-458 (1996).
96. Wiggers T, de Vries MR, Veeze-Kuypers B. Surgery for local recurrence of rectal carcinoma. Dis. Colon Rectum 39(3), 323-328 (1996).
97. Messiou C, Chalmers A, Boyle K, Sagar P. Surgery for recurrent rectal carcinoma: the role of preoperative magnetic resonance imaging. Clin. Radiol. 61(3), 250-258 (2006).
98. Garcia-Aguilar J, Cromwell JW, Marra C et al. Treatment of locally recurrent rectal cancer. Dis. Colon Rectum 44(12), 1743-1748 (2001).
99. Messiou C, Chalmers AG, Boyle K, Wilson D, Sagar P. Pre-operative MR assessment of recurrent rectal cancer. Br. J. Radiol. 81(966), 468-473 (2008).
100. Even-Sapir E, Parag Y, Lerman H et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 232(3), 815-822 (2004).
101. Yamada K, Ishizawa T, Niwak K, Chuman Y, Akiba S, Aikou T. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br. J. Surg. 88(7), 988-993 (2001).